Philogen Investor Relations Material

Philogen S.p.A. is an Italy-based biotechnology company focused on the research and development of targeted therapies for cancer and other serious diseases. The company specializes in antibody-based and small-molecule therapeutics, leveraging its expertise in tumor-targeting technologies. Philogen develops biologic drugs designed to deliver therapeutic agents directly to diseased tissues while minimizing effects on healthy cells. Its research spans from early discovery to clinical development, with a focus on immunotherapy and vascular targeting. The company is headquartered in Siena, Italy, and its shares are listed on the Borsa Italiana.